Ait Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, Golfier G et al (2007) Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. Am J Hum Genet 81:475–491
Article
CAS
PubMed
PubMed Central
Google Scholar
Ando K, Brion JP, Stygelbout V, Suain V, Authelet M, Dedecker R et al (2013) Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol 125:861–878
Article
CAS
PubMed
Google Scholar
Ando K, De Decker R, Vergara C, Yilmaz Z, Mansour S, Suain V, Sleegers K, de Fisenne MA, Houben S, Potier MC, Duyckaerts C, Watanabe T, Buée L, Leroy K, Brion JP. Acta Neuropathol. 2020;139(4):773-89.
Ando K, Leroy K, Heraud C, Yilmaz Z, Authelet M, Suain V et al (2011) Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. Am J Pathol 178:803–816
Article
CAS
PubMed
PubMed Central
Google Scholar
Ando K, Tomimura K, Sazdovitch V, Suain V, Yilmaz Z, Authelet M et al (2016) Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and pick disease. Neurobiol Dis 94:32–43
Article
CAS
PubMed
Google Scholar
Arai Y, Ijuin T, Itoh M, Takenawa T, Takashima S, Becker LE (2001) Developmental changes of synaptojanin expression in the human cerebrum and cerebellum. Brain Res Dev Brain Res 129:1–9
Article
CAS
PubMed
Google Scholar
Arai Y, Ijuin T, Takenawa T, Becker LE, Takashima S (2002) Excessive expression of synaptojanin in brains with Down syndrome. Brain and Development 24:67–72
Article
PubMed
Google Scholar
Augustinack JC, Schneider A, Mandelkow EM, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103:26–35
Article
CAS
PubMed
Google Scholar
Ball M, Braak H, Coleman P, Dickson D, Duyckaerts C, Gambetti P et al (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan institute working group on diagnostic criteria for the Neuropathological assessment of Alzheimer’s disease. Neurobiol Aging 18:S1–S2
Article
Google Scholar
Berman DE, Dall'Armi C, Voronov SV, McIntire LB, Zhang H, Moore AZ et al (2008) Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism. Nat Neurosci 11:547–554
Article
CAS
PubMed
PubMed Central
Google Scholar
Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M et al (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 184:247–263
Article
CAS
PubMed
Google Scholar
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
Article
CAS
PubMed
Google Scholar
Brion JP, Couck AM, Bruce M, Anderton B, Flament-Durand J (1991) Synaptophysin and chromogranin a immunoreactivities in senile plaques of Alzheimer's disease. Brain Res 539:143–150
Article
CAS
PubMed
Google Scholar
Brion JP, Hanger DP, Couck AM, Anderton BH (1991) A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities. Biochem J 279(Pt 3):831–836
Article
CAS
PubMed
PubMed Central
Google Scholar
Cao J, Gaamouch FE, Meabon JS, Meeker KD, Zhu L, Zhong MB et al (2017) ApoE4-associated phospholipid dysregulation contributes to development of tau hyper-phosphorylation after traumatic brain injury. Sci Rep 7:11372
Article
PubMed
PubMed Central
CAS
Google Scholar
Cao M, Wu Y, Ashrafi G, McCartney AJ, Wheeler H, Bushong EA et al (2017) Parkinson sac domain mutation in Synaptojanin 1 impairs Clathrin Uncoating at synapses and triggers dystrophic changes in dopaminergic axons. Neuron 93(882–896):e885
Google Scholar
Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157:277–286
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheon MS, Kim SH, Yaspo ML, Blasi F, Aoki Y, Melen K et al (2003) Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (part I). Amino Acids 24:111–117
Article
CAS
PubMed
Google Scholar
Cossec JC, Lavaur J, Berman DE, Rivals I, Hoischen A, Stora S et al (2012) Trisomy for synaptojanin1 in Down syndrome is functionally linked to the enlargement of early endosomes. Hum Mol Genet 21:3156–3172
Article
CAS
PubMed
PubMed Central
Google Scholar
Cremona O, Di Paolo G, Wenk MR, Luthi A, Kim WT, Takei K et al (1999) Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell 99:179–188
Article
CAS
PubMed
Google Scholar
Di Paolo G, De Camilli P (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443:651–657
Article
PubMed
CAS
Google Scholar
Dyment DA, Smith AC, Humphreys P, Schwartzentruber J, Beaulieu CL, Bulman DE et al (2015) Homozygous nonsense mutation in SYNJ1 associated with intractable epilepsy and tau pathology. Neurobiol Aging 36(1222):e1221–e1225
Google Scholar
Fulga TA, Elson-Schwab I, Khurana V, Steinhilb ML, Spires TL, Hyman BT et al (2007) Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo. Nat Cell Biol 9:139–148
Article
CAS
PubMed
Google Scholar
Galloway PG, Perry G, Gambetti P (1987) Hirano body filaments contain actin and actin-associated proteins. J Neuropathol Exp Neurol 46:185–199
Article
CAS
PubMed
Google Scholar
George AA, Hayden S, Stanton GR, Brockerhoff SE (2016) Arf6 and the 5'phosphatase of Synaptojanin 1 regulate autophagy in cone photoreceptors. Inside Cell 1:117–133
Article
PubMed
PubMed Central
CAS
Google Scholar
Greenberg SG, Davies P (1990) A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A 87:5827–5831
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirano A (1994) Hirano bodies and related neuronal inclusions. Neuropathol Appl Neurobiol 20:3–11
Article
CAS
PubMed
Google Scholar
Koh TW, Verstreken P, Bellen HJ (2004) Dap160/intersectin acts as a stabilizing scaffold required for synaptic development and vesicle endocytosis. Neuron 43:193–205
Article
CAS
PubMed
Google Scholar
Krebs CE, Karkheiran S, Powell JC, Cao M, Makarov V, Darvish H et al (2013) The Sac1 domain of SYNJ1 identified mutated in a family with early-onset progressive parkinsonism with generalized seizures. Hum Mutat 34:1200–1207
Article
CAS
PubMed
PubMed Central
Google Scholar
Krendel M, Osterweil EK, Mooseker MS (2007) Myosin 1E interacts with synaptojanin-1 and dynamin and is involved in endocytosis. FEBS Lett 581:644–650
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurbatskaya K, Phillips EC, Croft CL, Dentoni G, Hughes MM, Wade MA et al (2016) Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain. Acta Neuropathol Commun 4:34
Article
PubMed
PubMed Central
CAS
Google Scholar
Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000) Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360–364
Article
CAS
PubMed
Google Scholar
Leroy K, Ando K, Laporte V, Dedecker R, Suain V, Authelet M et al (2012) Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP/PS1 mice. Am J Pathol 181:1928–1940
Article
CAS
PubMed
Google Scholar
Leroy K, Brion JP (1999) Developmental expression and localization of glycogen synthase kinase-3beta in rat brain. J Chem Neuroanat 16:279–293
Article
CAS
PubMed
Google Scholar
Maciver SK, Harrington CR (1995) Two actin binding proteins, actin depolymerizing factor and cofilin, are associated with Hirano bodies. Neuroreport 6:1985–1988
Article
CAS
PubMed
Google Scholar
Makioka K, Yamazaki T, Takatama M, Ikeda M, Okamoto K (2014) Immunolocalization of Smurf1 in Hirano bodies. J Neurol Sci 336:24–28
Article
CAS
PubMed
Google Scholar
Maloney MT, Minamide LS, Kinley AW, Boyle JA, Bamburg JR (2005) Beta-secretase-cleaved amyloid precursor protein accumulates at actin inclusions induced in neurons by stress or amyloid beta: a feedforward mechanism for Alzheimer's disease. J Neurosci 25:11313–11321
Article
CAS
PubMed
PubMed Central
Google Scholar
Martin SB, Dowling AL, Lianekhammy J, Lott IT, Doran E, Murphy MP et al (2014) Synaptophysin and synaptojanin-1 in Down syndrome are differentially affected by Alzheimer's disease. J Alzheimers Dis 42:767–775
Article
CAS
PubMed
PubMed Central
Google Scholar
McPherson PS, Garcia EP, Slepnev VI, David C, Zhang X, Grabs D et al (1996) A presynaptic inositol-5-phosphatase. Nature 379:353–357
Article
CAS
PubMed
Google Scholar
McPherson PS, Takei K, Schmid SL, De Camilli P (1994) p145, a major Grb2-binding protein in brain, is co-localized with dynamin in nerve terminals where it undergoes activity-dependent dephosphorylation. J Biol Chem 269:30132–30139
CAS
PubMed
Google Scholar
Minamide LS, Striegl AM, Boyle JA, Meberg PJ, Bamburg JR (2000) Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function. Nat Cell Biol 2:628–636
Article
CAS
PubMed
Google Scholar
Miranda AM, Herman M, Cheng R, Nahmani E, Barrett G, Micevska E et al (2018) Excess Synaptojanin 1 contributes to place cell dysfunction and memory deficits in the aging Hippocampus in three types of Alzheimer's disease. Cell Rep 23:2967–2975
Article
CAS
PubMed
PubMed Central
Google Scholar
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130–133
Article
CAS
PubMed
Google Scholar
Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y et al (2016) The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments. Neuropathol Appl Neurobiol 42:639–653
Article
CAS
PubMed
Google Scholar
Nishikawa T, Takahashi T, Nakamori M, Yamazaki Y, Kurashige T, Nagano Y et al (2014) Phosphatidylinositol-4,5-bisphosphate is enriched in granulovacuolar degeneration bodies and neurofibrillary tangles. Neuropathol Appl Neurobiol 40:489–501
Article
CAS
PubMed
PubMed Central
Google Scholar
Nixon RA (2013) The role of autophagy in neurodegenerative disease. Nat Med 19:983–997
Article
CAS
PubMed
Google Scholar
Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J et al (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J Neurosci 26:10129–10140
Article
CAS
PubMed
PubMed Central
Google Scholar
Olgiati S, De Rosa A, Quadri M, Criscuolo C, Breedveld GJ, Picillo M et al (2014) PARK20 caused by SYNJ1 homozygous Arg258Gln mutation in a new Italian family. Neurogenetics 15:183–188
Article
CAS
PubMed
Google Scholar
Olney JW, Wozniak DF, Farber NB (1997) Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies. Arch Neurol 54:1234–1240
Article
CAS
PubMed
Google Scholar
Quadri M, Fang M, Picillo M, Olgiati S, Breedveld GJ, Graafland J et al (2013) Mutation in the SYNJ1 gene associated with autosomal recessive, early-onset parkinsonism. Hum Mutat 34:1208–1215
Article
CAS
PubMed
Google Scholar
Rudinskiy N, Grishchuk Y, Vaslin A, Puyal J, Delacourte A, Hirling H et al (2009) Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration. J Biol Chem 284:12447–12458
Article
CAS
PubMed
PubMed Central
Google Scholar
Sadleir KR, Kandalepas PC, Buggia-Prevot V, Nicholson DA, Thinakaran G, Vassar R (2016) Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Abeta generation in Alzheimer's disease. Acta Neuropathol 132:235–256
Article
CAS
PubMed
PubMed Central
Google Scholar
Saito K, Elce JS, Hamos JE, Nixon RA (1993) Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A 90:2628–2632
Article
CAS
PubMed
PubMed Central
Google Scholar
Sakisaka T, Itoh T, Miura K, Takenawa T (1997) Phosphatidylinositol 4,5-bisphosphate phosphatase regulates the rearrangement of actin filaments. Mol Cell Biol 17:3841–3849
Article
CAS
PubMed
PubMed Central
Google Scholar
Teipel SJ, Cavedo E, Weschke S, Grothe MJ, Rojkova K, Fontaine G et al (2017) Cortical amyloid accumulation is associated with alterations of structural integrity in older people with subjective memory complaints. Neurobiol Aging 57:143–152
Article
CAS
PubMed
Google Scholar
Thal DR, Rub U, Orantes M, Braak H (2002) Phases of a beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800
Article
PubMed
Google Scholar
Vanhauwaert R, Kuenen S, Masius R, Bademosi A, Manetsberger J, Schoovaerts N et al (2017) The SAC1 domain in synaptojanin is required for autophagosome maturation at presynaptic terminals. EMBO J 36:1392–1411
Article
CAS
PubMed
PubMed Central
Google Scholar
Vergara C, Houben S, Suain V, Yilmaz Z, De Decker R, Vanden Dries V et al (2019) Amyloid-beta pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathol 137:397–412
Article
CAS
PubMed
Google Scholar
Voronov SV, Frere SG, Giovedi S, Pollina EA, Borel C, Zhang H et al (2008) Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome. Proc Natl Acad Sci U S A 105:9415–9420
Article
CAS
PubMed
PubMed Central
Google Scholar
Wenk MR, Pellegrini L, Klenchin VA, Di Paolo G, Chang S, Daniell L et al (2001) PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse. Neuron 32:79–88
Article
CAS
PubMed
Google Scholar
Zhu L, Zhong M, Elder GA, Sano M, Holtzman DM, Gandy S et al (2015) Phospholipid dysregulation contributes to ApoE4-associated cognitive deficits in Alzheimer's disease pathogenesis. Proc Natl Acad Sci U S A 112:11965–11970
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu L, Zhong M, Zhao J, Rhee H, Caesar I, Knight EM et al (2013) Reduction of synaptojanin 1 accelerates Abeta clearance and attenuates cognitive deterioration in an Alzheimer mouse model. J Biol Chem 288:32050–32063
Article
CAS
PubMed
PubMed Central
Google Scholar